Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
The collaboration will leverage Graph's lab-in-the-loop platform with Parse's GigaLab to profile hundreds of millions of cells from patients with immune diseases under systematic perturbation, making ...
The widespread application of single-cell and spatial omics to models and patient samples has transformed immune cell profiling across physiological conditions. However, knowledge of immune cell ...
Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...
Immune-related adverse events (irAEs) are common and potentially fatal adverse events. However, predicting irAEs based on clinical medication regimens and basic patient information remains a ...
Adaptive Biotechnologies attracts attention as immune medicine innovation, diagnostic advancements, and biotechnology expansion continue to shape the healthcare sector.
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results